Global research trends in neurosyphilis: a bibliometric analysis from 2010 to 2024

Wei WeiFrontiers in Immunology 2025 · DOI

Abstract

Research on neurosyphilis is transitioning from traditional clinical descriptions toward multidisciplinary precision medicine. Future efforts should focus on integrating multi-omics technologies, establishing globally unified diagnostic criteria, and enhancing international collaboration to address the public health challenges posed by this disease.

Introduction

Neurosyphilis, a central nervous system infection caused by Treponema pallidum, is experiencing a global resurgence, particularly among HIV-positive populations. Despite its increasing prevalence, research has historically been fragmented across various medical disciplines. This study provides a comprehensive bibliometric map of neurosyphilis research from 2010 to 2024, utilizing AI-driven language models (BioBERT) alongside traditional mapping tools. It reveals a field in transition: moving away from basic clinical descriptions of "the great imitator" toward a multidisciplinary "precision medicine" approach focused on immune mechanisms and novel biomarkers like CXCL13.

Methodology

The study employed a dual-pronged analytical approach to synthesize 14 years of global data:

  1. Standard Bibliometrics: 863 articles were retrieved from the Web of Science Core Collection (WOSCC). Tools such as Bibliometrix (R package), VOSviewer, and CiteSpace were used to visualize collaboration networks and identify "citation bursts"—keywords that suddenly spike in frequency.
  2. AI-Enhanced Entity Extraction: In a novel application for bibliometrics, the authors utilized BioBERT, a pre-trained biomedical language representation model, to extract and analyze specific gene and molecule mentions within article abstracts.

The analysis shows a clear upward trajectory in both publication volume and citations over the last decade.

Annual publication and citation trends (2010-2024).

As shown in the figure above, the field reached a peak in 2024 with 112 articles. This growth reflects the increasing clinical importance of the disease and a renewed academic interest in its complex pathology.

Key Insights

The US-China Duopoly

Research is heavily concentrated, with the United States (27.3%) and China (26.9%) accounting for over half of all global publications. While the US leads in total citations, China’s publication volume has shown a more rapid upward trajectory in recent years. Prolific institutions include the University of Washington and Xiamen University, with researcher Marra Christina M. identified as a central figure in global collaboration networks.

The "Molecular Pivot"

Keyword evolution indicates a significant shift. Early research (2010–2014) focused on establishing diagnostic criteria and penicillin regimens. However, the period between 2021 and 2024 saw a surge in terms like "gene expression" and "transcriptomics," signaling a move toward identifying rare phenotypes and underlying genetic mechanisms.

Biomarkers and Molecular Targets

The analysis highlights CXCL13 as a critical research hotspot. This chemokine appears to be a more sensitive indicator of neurosyphilis activity than traditional markers, particularly in HIV-positive patients where standard cerebrospinal fluid (CSF) tests are often ambiguous. BioBERT analysis identified CD4 and CXCL13 as the most frequently studied molecular entities, followed by inflammatory cytokines like IL-6 and IL-1β.

Conclusion and Future Directions

While the field is advancing, several challenges remain. The current research is heavily influenced by English-language bias and a reliance on specific databases like WOSCC. Future research must integrate multi-omics (proteomics, metabolomics, etc.) to refine diagnostic accuracy. Furthermore, there is a pressing need for globally unified diagnostic criteria to resolve variability in clinical identification and enhance international collaboration to address the public health challenges posed by this disease.

Summary updated

Abstract

Research on neurosyphilis is transitioning from traditional clinical descriptions toward multidisciplinary precision medicine. Future efforts should focus on integrating multi-omics technologies, establishing globally unified diagnostic criteria, and enhancing international collaboration to address the public health challenges posed by this disease.
BibTeX
@inproceedings{wei2025global,
  author = {Wei Wei and Li Wei},
  title = {{Global research trends in neurosyphilis: a bibliometric analysis from 2010 to 2024}},
  booktitle = {Frontiers in Immunology},
  year = {2025},
  doi = {10.3389/fimmu.2025.1649106},
}
Figure